Retrospective Cohort Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. Aug 14, 2015; 21(30): 9118-9125
Published online Aug 14, 2015. doi: 10.3748/wjg.v21.i30.9118
Table 1 Patient characteristics
Anastomotic leakage (n = 15)No anastomotic leakage (n = 74)P value
Sex1.001
Male12 (80)59 (80)
Female3 (20)15 (20)
Age71 (64-76)65 (57-69)0.012
Steroid use1 (7)2 (3)0.431
Comorbidity11 (73)51 (69)1.001
Cardiac2 (13)18 (24)0.511
Vascular4 (27)34 (46)0.251
Diabetes4 (27)18 (24)1.001
Pulmonary5 (33)17 (23)0.403
Renal0 (0)1 (1)1.001
BMI > 30 kg/m23 (20)13 (18)0.731
ASA score0.462
I1 (7)5 (7)
II11 (73)46 (62)
III3 (20)23 (31)
Neoadjuvant therapy0.762
None0 (0)6 (8)
Chemotherapy0 (0)4 (5)
Chemoradiotherapy15 (100)65 (87)
Jejunostomy6 (40)24 (32)0.573
Start of oral feeding (POD)1 (1-1)1 (1-1)0.462
Table 2 Intrathoracic anastomotic leakage n (%)
n = 15/89 (16.9)
Intervention type
Antibiotics and NPO8 (9.0)
Endoscopic stent3 (3.4)
Surgical reintervention4 (4.5)
According to Clavien-Dindo
Grade II0 (0)
Grade IIIa9 (10.1)
Grade IIIb0 (0)
Grade IVa6 (6.7)
Table 3 Diagnostic value of drain amylase
Time of measurementAUCCut-off (IU/L)SensitivitySpecificityRR
Per postoperative day
POD 10.67235021.495.63.5a
POD 20.67620026.495.74.0a
POD 30.68516035.794.04.4a
Any POD
Same cut-off as Machens et al[17]60053.397.39.0a
Most accurate in our cohort190053.398.710.2a